drugset / Trial / NCT02453373

Helping Stroke Patients With ThermoSuit Cooling

NCT02453373

Non-randomizedParallel-groupDouble-blindTreatment

Summary

The aim of this study is to assess the feasibility of using the Life Recovery Systems ThermoSuit Device to induce therapeutic hypothermia (32-34°C) in victims of ischemic stroke. This feasibility clinical study will enroll a total of 30 patients with acute ischemic stroke at four clinical centers. Subjects will receive hypothermia plus conventional therapy (such as IV-tPA and/or neurothrombectomy therapies if indicated). Endpoints will include feasibility of cooling, adverse events, and neurological recovery in comparison with matched historical controls.

Timeline

Start
2017-01-25
Primary completion
2023-06-01
Completion
2023-06-02

Drugs

EvaluationDrugModalityDoseRoute
Background Etomidate Small molecule
Background Magnesium Sulfate Other / unclassified Intravenous
Background Propofol Small molecule
Background tPA Unknown Intravenous